You are here: Industry Insights > blood clots

News List

FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations FDA
December 22, 2021
FDA has approved Xarelto (rivaroxaban) as tablets and an oral suspension to treat venous thromboembolism (VTE), or blood clots that form in the veins, and reduce the risk of VTE recurring in pediatric patients...
Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine PharmaTimes
December 03, 2021
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Novel Autoantibody Adds Fuel to COVID-19 “Firestorm” of Inflammation, Blood Clots firstwordpharma
July 20, 2021
Researchers at Michigan Medicine have discovered yet another functional autoantibody in COVID-19 patients that contributes to the disease's development and the "firestorm" of blood clots and inflammation it induces.
Heparin may cut risk of severe disease and death in COVID-19 patients: Study expresspharma
July 16, 2021
The study showed that therapeutic heparin is beneficial in moderately ill hospitalised patients but not in severely ill ICU patients.
NICE to develop guideline for rare blood clots associated with COVID-19 vaccination pharmatimes
July 15, 2021
The National Institute for Health and Care Excellence (NICE) will develop a guideline on the management and treatment of rare blood clots and low platelet counts associated with COVID-19 vaccination.
Researchers in Ireland identify the reason COVID-19 patients develop blood clots expresspharma
June 18, 2021
The blood of COVID-19 patients had higher levels of the pro-clotting VWF molecules and lower levels of the anti-clotting ADAMTS13.
US allows J&J COVID-19 vaccine shots to resume expresspharma
April 25, 2021
The United States can immediately resume the use of Johnson & Johnson’s COVID-19 vaccine, top health regulators said, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots.
EMA confirms Janssen COVID-19 Vaccine benefits outweigh clotting risks europeanpharmaceuticalreview
April 22, 2021
The EMA’s drug safety committee has concluded that the Janssen COVID-19 Vaccine is safe for continued use, so Johnson & Johnson will resume shipments to the EU.
Benefits of AZ vaccine outweigh risks, says MHRA pharmatimes
April 08, 2021
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that there is a possible link between AstraZeneca's COVID-19 vaccine and “extremely rare, unlikely to occur blood clots”.
Denmark suspends AZ/Oxford Covid-19 vaccination amid blood clot concerns pharmaceutical-technology
March 12, 2021
The Danish National Board of Health has temporarily paused the roll-out of the AstraZeneca/Oxford Covid-19 vaccine.

Previous page 1 2 Next page